Download | < Back |
28 Oct 2021 | |
Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations,<BR> 2015 as amended, please find enclosed a copy of the Monitoring agency report of the Company for the<BR> quarter ended 30 September 2021, issued by ICICI Bank Limited, appointed to monitor the utilization of<BR> proceeds of an Initial Public Offering ('IPO') of the Company.<BR> Request you to please take the above on record. | |
View all announcements for Tatva Chintan Pharma Chem Ltd | Source: BSE India |